| Trial ID: | L5896 |
| Source ID: | NCT02029846
|
| Associated Drug: |
Standard Treatment
|
| Title: |
Glycemia in Diabetic Elders Trial
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT02029846/results
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Standard Treatment|DRUG: Incretin-Based Treatment
|
| Outcome Measures: |
Primary: Time to Achieve Glycemic Target (HbA1c <7.5%)., Data not analyzed due to n=1 each arm., 6 months | Secondary: Overall Hypoglycemia Measured by Glucose Meter, Data not analyzed due to n=1 each arm., 6 months | Other: Diabetes Quality of Life, Data not analyzed due to n=1 each arm, 6 months
|
| Sponsor/Collaborators: |
Sponsor: Johns Hopkins University
|
| Gender: |
ALL
|
| Age: |
OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
2
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2013-04
|
| Completion Date: |
2017-02
|
| Results First Posted: |
2017-05-25
|
| Last Update Posted: |
2023-04-18
|
| Locations: |
Bay West Endocrinology Associates, Baltimore, Maryland, 21204, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT02029846
|
